Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine 3mL vs 5mL for Interscalene Block
NCT04317235Completed
- Sponsor
- Saint George Hospital University Medical Center
- Start
- Jan 2016
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
01
Overview
Randomised, triple-blind trial of ropivacaine, sponsored by Saint George Hospital University Medical Center. Primary endpoints: Diaphragmatic paralysis at 48 hours and Pain relief at 2 days. Started Jan 2016; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on NCT04317235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04317235.